Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biopharma crawled date : 2022 - 11 - 01 save search
Ambrx Biopharma Inc. Appoints Daniel O’Connor as Chief Executive Officer
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: -1.5%
H: 2.63%
C: -5.95%
ADXS | $0.6455 12.48% 2.3K
|
Health Technology
|
| O: 4.84%
H: 0.0%
C: -4.62%
biopharma
Xeris Biopharma Announces Results of the Extended Evaluation of Recorlev® (Levoketoconazole) From the Phase 3 Sonics Study Published in the European Journal of Endocrinology
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
XERS | $1.77 -0.56% -0.56% 1.1M
|
Health Technology
|
| O: 0.63%
H: 1.24%
C: -1.24%
recorlev biopharma results study
GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
GTBP | $3.97 1.3% 1K
|
Manufacturing
|
| O: 0.52%
H: 0.0%
C: -4.62%
biopharma financial update results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.